These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 15308367)

  • 61. Measles supplemental immunization activities improve measles vaccine coverage and equity: Evidence from Kenya, 2002.
    Vijayaraghavan M; Martin RM; Sangrujee N; Kimani GN; Oyombe S; Kalu A; Runyago A; Wanjau G; Cairns L; Muchiri SN
    Health Policy; 2007 Sep; 83(1):27-36. PubMed ID: 17174435
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Economic evaluation of measles catch-up and follow-up campaigns in Afghanistan in 2002 and 2003.
    Vijayaraghavan M; Lievano F; Cairns L; Wolfson L; Nandy R; Ansari A; Golaz A; Mashal T; Salama P
    Disasters; 2006 Jun; 30(2):256-69. PubMed ID: 16689921
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Economic evaluation of varicella vaccination in Spain: results from a dynamic model.
    Lenne X; Diez Domingo J; Gil A; Ridao M; Lluch JA; Dervaux B
    Vaccine; 2006 Nov; 24(47-48):6980-9. PubMed ID: 16860909
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The measles campaign in West and Central Africa: remembering the future.
    De Groot A; Bamba SI; Bougoudogo F
    Vaccine; 2008 Jul; 26(31):3783-6. PubMed ID: 18582995
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Measles throughout the world].
    Gateff C
    Med Trop (Mars); 1985; 45(1):19-25. PubMed ID: 2581109
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised cases.
    Bonanni P; Boccalini S; Bechini A; Banz K
    Vaccine; 2008 Oct; 26(44):5619-26. PubMed ID: 18723062
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A 24-year review on the epidemiology and control of measles in Singapore, 1981-2004.
    Ong G; Hoon HB; Ong A; Chua LT; Kai CS; Tai GK
    Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):96-101. PubMed ID: 16771219
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The average cost of measles cases and adverse events following vaccination in industrialised countries.
    Carabin H; Edmunds WJ; Kou U; van den Hof S; Nguyen VH
    BMC Public Health; 2002 Sep; 2():22. PubMed ID: 12241559
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Measles vaccine adverse events reported in the mass vaccination campaign of Sichuan province, China from 2007 to 2008.
    Shu M; Liu Q; Wang J; Ao R; Yang C; Fang G; Wan C; Guo W
    Vaccine; 2011 Apr; 29(18):3507-10. PubMed ID: 19909830
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cost-effectiveness evaluation of measles immunization strategies on a college campus.
    Shlian DM; Matchar D; Seymann GB
    Fam Pract Res J; 1991 Jun; 11(2):193-207. PubMed ID: 1905455
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [An economic evaluation of measles vaccination in District 3 of the city of Bucharest].
    Ion-Nedelcu N; Mihăileanu C; Dobrescu A
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1989; 34(2):163-8. PubMed ID: 2506626
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Measles outbreak in South Africa: epidemiology of laboratory-confirmed measles cases and assessment of intervention, 2009-2011.
    Ntshoe GM; McAnerney JM; Archer BN; Smit SB; Harris BN; Tempia S; Mashele M; Singh B; Thomas J; Cengimbo A; Blumberg LH; Puren A; Moyes J; van den Heever J; Schoub BD; Cohen C
    PLoS One; 2013; 8(2):e55682. PubMed ID: 23437059
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Measles outbreak after a post-honeymoon period in Mongolia, 2001.
    Rentsen T; Enkhtuya B; Nymadawa P; Kobune F; Suzuki K; Yoshida H; Hachiya M
    Jpn J Infect Dis; 2007 Jul; 60(4):198-9. PubMed ID: 17642531
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Health burden and economic impact of measles-related hospitalizations in Italy in 2002-2003.
    Filia A; Brenna A; Panà A; Cavallaro GM; Massari M; Ciofi degli Atti ML
    BMC Public Health; 2007 Jul; 7():169. PubMed ID: 17650298
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Migration as a risk factor for measles after a mass vaccination campaign, Burkina Faso, 2002.
    Yaméogo KR; Perry RT; Yaméogo A; Kambiré C; Kondé MK; Nshimirimana D; Kezaala R; Hersh BS; Cairns KL; Strebel P
    Int J Epidemiol; 2005 Jun; 34(3):556-64. PubMed ID: 15659463
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Economic evaluation of an extended acellular pertussis vaccine programme for adolescents in Ontario, Canada.
    Iskedjian M; Walker JH; Hemels ME
    Vaccine; 2004 Oct; 22(31-32):4215-27. PubMed ID: 15474711
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda.
    Bishai D; Johns B; Nair D; Nabyonga-Orem J; Fiona-Makmot B; Simons E; Dabbagh A
    J Infect Dis; 2011 Jul; 204 Suppl 1(Suppl 1):S107-15. PubMed ID: 21666151
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Value of a mass vaccination campaign: measles cases in the hospital milieu in Brazzaville (Congo)].
    Obengui P; Nkoua JL; Moyen G; Nzingoula S
    Bull Soc Pathol Exot; 1993; 86(4):243-4. PubMed ID: 8292911
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of immunity against rubella in Iranian after mass campaign for measles-rubella vaccination on December 2003.
    Hamkar R; Jalilvand S; Mokhtari-Azad T; Jelyani KN; Nategh R
    Am J Infect Control; 2006 Nov; 34(9):588-92. PubMed ID: 17097454
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Progress in measles control--Kenya 2002-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(37):969-72. PubMed ID: 17882128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.